basal insulinmetforminweight gainglycaemic controlThe aim of this retrospective study was to compare glycaemic control and weight gain in patients with type 2 diabetes (T2DM) commenced on basal insulin (Bl) or mixed insulin (Ml). Subjects had T2DM (mean duration seven years) poorly controlled ...
n.insulina. hormona secretada en el páncreas; ___ dependent→insulinodependiente. English-Spanish Medical Dictionary © Farlex 2012 insulin ninsulina;basal —insulina basal;human —insulina humana;— analogueanálogo de la insulina;— aspartinsulina aspart, insulina asparta (INN);— detemirin...
Basal/Bolus Insulin Therapy: A Need for Two Daily NPH DosesIGOR BJELINSKIIVANA PAVLICRENARDIJANA BJELINSKIZELJKO METELKO
Conversion from bedtime NPH to morning glargine appears efficacious with no increase in frequency of hypoglycemia. 展开 关键词: Glargine Intensive insulin therapy Type 2 diabetes Basal-prandial insulin therapy DOI: 10.1016/j.diabres.2005.12.009 被引量: 84 ...
Initiation of insulin therapy for type 2 diabetes mellitus This program is designed to identify patients in whom diabetes mellitus resists therapy with oral hypoglycemic agents (OHA) and basal insulin administratio... MB Antsiferov,MB Antsiferov - 《Problemy Endokrinologii》 被引量: 0发表: 2009...
AIMS/HYPOTHESIS: The aim of the trial was to compare the efficacy and tolerability of two types of basal-bolus therapy, using either the soluble long-acting basal insulin analogue, insulin detemir, in combination with the rapid-acting analogue, insulin aspart, or NPH insulin in combination with...
This 6-month, open-label, observational study assessed the efficacy and safety of switching Japanese patients with type 2 diabetes from neutral protamine Hagedorn (NPH) insulin to insulin detemir. METHODS: Patients with type 2 diabetes (= 126) receiving basal—bolus insulin therapy with NPH ...
Patients were randomized in a 2:1 ratio to receive either detemir or glargine for 52 weeks. The basal insulin was initially adm... S Heller,C Koenen,B Bode - 《Clinical Therapeutics》 被引量: 141发表: 2009年 Defining the role of insulin detemir in Basal insulin therapy. Most trials have...
Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from P. Dornhorst,L眉ddeke,Koenen,Meril?inen,...
The aim of this retrospective study was to compare glycaemic control and weight gain in patients with type 2 diabetes (T2DM) commenced on basal insulin (BI) or mixed insulin (MI).Subjects had T2DM (mean duration seven years) poorly controlled while treated with oral hypoglycaemic agents. Two ...